Robert E. Waltermire, Senior Vice President and Chief Pharma Development Officer at Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company with a market capitalization of $6.39 ...
Rebecca Taub, President of Research and Development and Chief Medical (TASE:PMCN) Officer at Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), recently sold 1,689 shares of the company's common stock. The ...